Karo Pharma AB Stock
Karo Pharma AB Stock
Karo Pharma AB is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
Based on the current price of 5.44 € the target price of 56 € shows a potential of 929.41% for Karo Pharma AB which would more than double the current price.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Medivir AB | 4.820% | -3.687% | 15.575% | -21.230% | 284.118% | -78.363% | -86.480% |
| NanoViricides Inc. | 1.520% | 0.000% | 11.667% | -6.944% | 44.086% | -2.190% | -60.472% |
| Ocuphire Pharma Inc. | -1.800% | 18.382% | -9.551% | 228.236% | 91.439% | -17.857% | -9.551% |
Comments
Karooooo (KARO) had its price target raised by Raymond James Financial, Inc. from $60.00 to $75.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by Roth Capital.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for KARO provided by MarketBeat